LONDON, April 18, 2017 /PRNewswire/ -- The global Cancer/Tumor Profiling market is poised to reach USD 61.87 billion by 2021 from USD 25.82 billion in 2016, at a CAGR of 19.1% from 2016 to 2021. Increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research are the major factors driving the growth of the global Cancer/Tumor Profiling market.Download the full report: https://www.reportbuyer.com/product/4450353/In recent years, the Asia-Pacific market for cancer/tumor profiling has witnessed significant growth due to the rising incidence of cancer, increasing demand for better healthcare services in developing economies such as India and China, rising number of contract research organizations (CROs), and increasing focus of international players on emerging markets. In this report, the global Cancer/Tumor Profiling market is segmented on the basis of technology, technique, application, and region. On the basis of technology, the global cancer/tumor profiling market is broadly divided into next-generation sequencing, quantitative PCR, in situ hybridization, immunohistochemistry, and microarray. The next-generation sequencing segment is expected to account for the largest share of the cancer/tumor profiling technology market in 2016. Factors contributing to its largest share include advantages such as reduction in sequencing costs, technology advancements in sequencing platforms, research laboratories and academicians promoting the use of NGS. Furthermore, based on technique, the cancer/tumor profiling market is segmented into genomics, proteomics, epigenetics, and metabolomics. The genomics segment is expected to account for the largest share of the cancer/tumor profiling technique market in 2016. Factors such as increasing investments, grants, and funds by governments; growing research in the field of genomics; and rising application of genomic sequencing in diagnostics are contributing to the growth of this segment.Based on technology, the global cancer/tumor profiling market is broadly divided into next-generation sequencing, quantitative PCR, in situ hybridization, immunohistochemistry, and microarray. The next-generation sequencing segment is expected to account for the largest share of the cancer/tumor profiling technology market in 2016. Factors such as reduction in sequencing costs, technology advancements in sequencing platforms, research laboratories and academicians promoting the use of NGS, and increasing awareness on NGS products and services are contributing to the growth of this segment.New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.Research Coverage:From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the cancer/tumor profiling market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.Reasons to buy this report:From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the single-use bioprocessing market; high-growth regions; and market drivers, restraints, and opportunities.The report provides insights on the following pointers:- Market Penetration: Comprehensive information on products offered by the top players in the cancer/tumor profiling market- Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the cancer/tumor profiling market- Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for cancer/tumor profiling products across various regions- Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the cancer/tumor profiling market - Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the cancer/tumor profiling marketDownload the full report: https://www.reportbuyer.com/product/4450353/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected]
Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cancertumor-profiling-market-by-application-techniquetechnology--forecast-to-2021-300441321.html
SOURCE ReportBuyer
